JessicaE(Ravikoff)AllegrettiMD

Associate Director, Crohn’s and Colitis Center

Dr. Allegretti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Jessica Allegretti is a gastroenterologist in Boston, MA and is affiliated with Brigham and Women's Hospital. She received her medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 8 years. She is experienced in inflammatory bowel disease.

PubMed

1 citations
International consensus statement on microbiome testing in clinical practice.
Serena Porcari, Benjamin H Mullish, Francesco Asnicar, Siew C Ng, Liping Zhao
The Lancet. Gastroenterology & Hepatology. 2025-02-01
5 citations
Diet and Microbiome-Directed Therapy 2.0 for IBD.
Ashwin N Ananthakrishnan, Kevin Whelan, Jessica R Allegretti, Harry Sokol
Clinical Gastroenterology and Hepatology. 2025-02-01
2 citations
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized...
Jessica R Allegretti, Colleen R Kelly, Thomas Louie, Monika Fischer, Susy Hota
Gastroenterology. 2025-02-01

Lectures

Clostridium difficile: Are We Making Progress?
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/6/2018

Four Analyses of Data for REBYOTA™ (Fecal Microbiota, Live – Jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. Difficile Infection, Presented at DDW 2023May 8th, 2023
FMT Tops Standard of Care for First or Second C. Diff InfectionsSeptember 29th, 2022
Opinion: Splashing Cold Water on Poop Transplants for Weight LossSeptember 1st, 2022
Join now to see all